Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
- 25 April 2006
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (10) , 2851-2857
- https://doi.org/10.1021/jm060009x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- CCR5 Deficiency Exacerbates T-Cell–Mediated Hepatitis in Mice *Hepatology, 2005
- Potential therapeutic targets for neurokinin-1 receptor antagonistsEmerging Drugs, 2004
- Toxicity of antiretroviral therapy and implications for drug developmentNature Reviews Drug Discovery, 2003
- Large-scale manufacture of peptide therapeutics by chemical synthesisNature Reviews Drug Discovery, 2003
- HIV chemotherapyNature, 2001
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Chemokine receptors and the clinical course of HIV-1 infectionTrends in Microbiology, 1998
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986